Current topics on therapeutic apheresis

Journal of Artificial Organs

Volumn 13, Issue 2, 2010, Pages 73-76

  Yamaji, Ken ^a  

^a NONE

Author keywords

Chronic hepatitis C; Dilatative cardiomyopathy; Pyoderma gangrenosum; Rheumatoid arthritis; Ulcerative colitis

Indexed keywords

INTERFERON; PEGINTERFERON; RIBAVIRIN;

APHERESIS; CLINICAL EFFECTIVENESS; CONGESTIVE CARDIOMYOPATHY; CYTAPHERESIS; GRANULOCYTAPHERESIS; HEALTH INSURANCE; HEPATITIS C; HUMAN; LEUKOCYTAPHERESIS; LUNG FIBROSIS; PLASMAPHERESIS; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT INDICATION; ULCERATIVE COLITIS; ARTHRITIS, RHEUMATOID; CARDIOMYOPATHY, DILATED; COLITIS, ULCERATIVE; HEPATITIS C, CHRONIC; PROCEDURES; PULMONARY FIBROSIS; TREATMENT OUTCOME;

ARTHRITIS, RHEUMATOID; BLOOD COMPONENT REMOVAL; CARDIOMYOPATHY, DILATED; COLITIS, ULCERATIVE; HEPATITIS C, CHRONIC; HUMANS; PULMONARY FIBROSIS; PYODERMA GANGRENOSUM; TREATMENT OUTCOME;

EID: 77956454414     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10047-010-0501-4     Document Type: Review

References (19)

1. Kempe K, Tsuda H, Yang K, Yamaji K, Kanai Y, Hashimoto H. Filtration leukocytapheresis therapy in the treatment of rheumatoid arthritis patients resistant to or failed with methotrexate. Ther Apher Dial. 2004;8:197-205.
2. Onuma S, Yamaji K, Kempe K, Ogasawara M, Ogawa T, Yang K, et al. Investigation of the clinical effect of large volume leukocytapheresis on methotrexate-resistant rheumatoid arthritis. Ther Apher Dial. 2006;10:404-11.
3. Eguchi K, Saito K, Kondo M, Hidaka T, Ueki Y, Tanaka Y. LCAP Investigators in Kyushu College of Rheumatology (LIKCR). Enhanced effect of high-dose leukocytapheresis using a large filter in rheumatoid arthritis. Mod Rheumatol. 2007;17:481-5.
4. Yamaji K, Yang KS, Tsuda H, Hashimoto H. Fluctuations in the peripheral blood leukocyte and platelet counts in leukocytapheresis in healthy volunteers. Ther Apher. 2002;6:402-12.
5. Hidaka T, Suzuki K, Matsuki Y, Takamizawa-Matsumoto M, Okada M, Ishizuka T, et al. Changes in CD4+ T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. Ther Apher. 1999;3:178-85.
6. Hidaka T, Suzuki K, Kawakami M, Okada M, Kataharada K, Shinohara T, et al. Dynamic changes in cytokine levels in serum and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. J Clin Apher. 2001;16:74-81.
7. Yamaji K. Effect and mechanism of leukocytapheresis for rheumatoid arthritis (in Japanese). Jpn J Apher. 2007;26:58.
8. Suzuki Y. Grant-in-Aid for Scientific Research, Research project for specific diseases control measures, Multicenter Study of effect of leukopheresis/adsorption therapy on inflammatory bowel disease (in Japanese). 1999 Research Report; 1999. p. 12-15.
9. Sakuraba A, Sato T, Naganuma M, Morohoshi Y, Matsuoka K, Inoue N, et al. A pilot-labeled prospective randomized study between weekly and intensive treatment with granulocyte and monocyte adsorption apheresis for active ulcerative colitis. J Gastroenterol. 2008;43:51-6.
10. Fujiwara K, Kaneko S, Kakumu S, Sata M, Hige S, Tomita E, et al. Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load. Hepatol Res. 2007;37:701-10.
11. Hare JM. The dilated, restrictive, and infiltrative cardiomyopathies. In: Libby P, Bonow RO, Mann DL, Zipes DP, editors. Braunwald's heart disease. 8th ed. Philadelphia: W. B. Saunders; 2008. p. 1746.
12. Wallukat G, Reinke P, Dorffel WV, Luther HP, Bestvater K, Felix SB, et al. Removal of autoantibodies in dilated cardiomy-opathy by immunoadsorption. Int J Cardiol. 1996;54:191-5.
13. Baba A, Murakami A, Wakabayashi Y. Identification of beneficial adsorbers for immunoadsorption in Japanese patients with dilated cardiomyopathy (in Japanese). Jpn J Apher. 2004;23:101-2.
14. Baba A. Immunoadsorption of dilatated cardiomyopathy (in Japanese). Respir Circ. 2008;56:371-5.
15. Kanekura T, Maruyama I, Kanzaki T. Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum. J Am Acad Dermatol. 2002;47:320-1.
16. Seishima M, Mizutani Y, Shibuya Y, Nagasawa C, Aoki T. Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum. Ther Apher Dial. 2007;11:177-82.
17. Fujimoto E, Fujimoto N, Kuroda K, Tajima S. Leukocytapheresis treatment for pyoderma gangrenosum. Br J Dermatol. 2004;151: 1090-2.
18. Seo Y, Abe S, Kurahara M, Okada D, Saito Y, Usuki J, et al. Beneficial effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on acute exacerbation of idiopathic pulmonaryfibrosis. Intern Med. 2006;45:1033-8.
19. Kushi H, Miki T, Okamoto K, Nakahara J, Saito T, Tanjoh K. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Clin care. 2005;9:R653-61.